Global Circadian Rhythm Sleep Disorders Drug Market Growth (Status and Outlook) 2025-2031

Product Code: 1267278

Industry: Medical Care

Published: Jul 11,2025

Pages: 90

Delivery Time: 2-3 business days

Global Circadian Rhythm Sleep Disorders Drug Market Growth (Status and Outlook) 2025-2031

Product Code: 1267278

Industry: Medical Care

Published: Jul 11,2025

Pages: 90

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to this study, the global Circadian Rhythm Sleep Disorders Drug market size will reach US$ 1063 million by 2031.

Circadian Rhythm Sleep Disorders (CRSDs) Drugs are medications used to manage sleep disorders caused by misalignments in a person’s internal biological clock — the circadian rhythm — which controls the sleep–wake cycle over a roughly 24-hour period.

The global Circadian Rhythm Sleep Disorders market is set for continued growth driven by increased awareness, advancements in treatment options, and technological innovations. The emphasis on personalized medicine, improved diagnostic tools, and a growing focus on sleep health and wellness are key factors contributing to market expansion. However, challenges such as regional disparities in awareness and the cost of advanced treatments remain. Ongoing research and development will play a crucial role in shaping the future of the market.

LPI (LP Information)' newest research report, the “Circadian Rhythm Sleep Disorders Drug Industry Forecast” looks at past sales and reviews total world Circadian Rhythm Sleep Disorders Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Circadian Rhythm Sleep Disorders Drug sales for 2025 through 2031. With Circadian Rhythm Sleep Disorders Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circadian Rhythm Sleep Disorders Drug industry.

This Insight Report provides a comprehensive analysis of the global Circadian Rhythm Sleep Disorders Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Circadian Rhythm Sleep Disorders Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circadian Rhythm Sleep Disorders Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circadian Rhythm Sleep Disorders Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circadian Rhythm Sleep Disorders Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Circadian Rhythm Sleep Disorders Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Melatonin
    Ramelteon
    Others

Segmentation by Application:
    Delayed Sleep Phase Syndrome (DSPS)
    Advanced Sleep Phase Syndrome (ASPS)
    Irregular Sleep-Wake Disorder (ISWD)
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Teva Pharmaceuticals
    Takeda Pharmaceutical
    NBTY
    Vicks (Procter & Gamble)
    Natrol
    Nature Made (Pharmavite)
    Jameison
    GNC
    By-Health
    Now Foods

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Circadian Rhythm Sleep Disorders Drug Market Size (2020-2031)
        2.1.2 Circadian Rhythm Sleep Disorders Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Circadian Rhythm Sleep Disorders Drug by Country/Region (2020, 2024 & 2031)
    2.2 Circadian Rhythm Sleep Disorders Drug Segment by Type
        2.2.1 Melatonin
        2.2.2 Ramelteon
        2.2.3 Others
    2.3 Circadian Rhythm Sleep Disorders Drug Market Size by Type
        2.3.1 Circadian Rhythm Sleep Disorders Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type (2020-2025)
    2.4 Circadian Rhythm Sleep Disorders Drug Segment by Application
        2.4.1 Delayed Sleep Phase Syndrome (DSPS)
        2.4.2 Advanced Sleep Phase Syndrome (ASPS)
        2.4.3 Irregular Sleep-Wake Disorder (ISWD)
        2.4.4 Others
    2.5 Circadian Rhythm Sleep Disorders Drug Market Size by Application
        2.5.1 Circadian Rhythm Sleep Disorders Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application (2020-2025)

3 Circadian Rhythm Sleep Disorders Drug Market Size by Player
    3.1 Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Player
        3.1.1 Global Circadian Rhythm Sleep Disorders Drug Revenue by Player (2020-2025)
        3.1.2 Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Player (2020-2025)
    3.2 Global Circadian Rhythm Sleep Disorders Drug Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Circadian Rhythm Sleep Disorders Drug by Region
    4.1 Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025)
    4.2 Global Circadian Rhythm Sleep Disorders Drug Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Circadian Rhythm Sleep Disorders Drug Market Size Growth (2020-2025)
    4.4 APAC Circadian Rhythm Sleep Disorders Drug Market Size Growth (2020-2025)
    4.5 Europe Circadian Rhythm Sleep Disorders Drug Market Size Growth (2020-2025)
    4.6 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)
    5.2 Americas Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025)
    5.3 Americas Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025)
    6.2 APAC Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025)
    6.3 APAC Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025)
    7.2 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025)
    7.3 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Circadian Rhythm Sleep Disorders Drug by Region (2020-2025)
    8.2 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025)
    8.3 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Circadian Rhythm Sleep Disorders Drug Market Forecast
    10.1 Global Circadian Rhythm Sleep Disorders Drug Forecast by Region (2026-2031)
        10.1.1 Global Circadian Rhythm Sleep Disorders Drug Forecast by Region (2026-2031)
        10.1.2 Americas Circadian Rhythm Sleep Disorders Drug Forecast
        10.1.3 APAC Circadian Rhythm Sleep Disorders Drug Forecast
        10.1.4 Europe Circadian Rhythm Sleep Disorders Drug Forecast
        10.1.5 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Forecast
    10.2 Americas Circadian Rhythm Sleep Disorders Drug Forecast by Country (2026-2031)
        10.2.1 United States Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.2.2 Canada Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.2.3 Mexico Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.2.4 Brazil Market Circadian Rhythm Sleep Disorders Drug Forecast
    10.3 APAC Circadian Rhythm Sleep Disorders Drug Forecast by Region (2026-2031)
        10.3.1 China Circadian Rhythm Sleep Disorders Drug Market Forecast
        10.3.2 Japan Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.3.3 Korea Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.3.4 Southeast Asia Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.3.5 India Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.3.6 Australia Market Circadian Rhythm Sleep Disorders Drug Forecast
    10.4 Europe Circadian Rhythm Sleep Disorders Drug Forecast by Country (2026-2031)
        10.4.1 Germany Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.4.2 France Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.4.3 UK Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.4.4 Italy Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.4.5 Russia Market Circadian Rhythm Sleep Disorders Drug Forecast
    10.5 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Forecast by Region (2026-2031)
        10.5.1 Egypt Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.5.2 South Africa Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.5.3 Israel Market Circadian Rhythm Sleep Disorders Drug Forecast
        10.5.4 Turkey Market Circadian Rhythm Sleep Disorders Drug Forecast
    10.6 Global Circadian Rhythm Sleep Disorders Drug Forecast by Type (2026-2031)
    10.7 Global Circadian Rhythm Sleep Disorders Drug Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Circadian Rhythm Sleep Disorders Drug Forecast

11 Key Players Analysis
    11.1 Teva Pharmaceuticals
        11.1.1 Teva Pharmaceuticals Company Information
        11.1.2 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Product Offered
        11.1.3 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 Teva Pharmaceuticals Main Business Overview
        11.1.5 Teva Pharmaceuticals Latest Developments
    11.2 Takeda Pharmaceutical
        11.2.1 Takeda Pharmaceutical Company Information
        11.2.2 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Product Offered
        11.2.3 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 Takeda Pharmaceutical Main Business Overview
        11.2.5 Takeda Pharmaceutical Latest Developments
    11.3 NBTY
        11.3.1 NBTY Company Information
        11.3.2 NBTY Circadian Rhythm Sleep Disorders Drug Product Offered
        11.3.3 NBTY Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 NBTY Main Business Overview
        11.3.5 NBTY Latest Developments
    11.4 Vicks (Procter & Gamble)
        11.4.1 Vicks (Procter & Gamble) Company Information
        11.4.2 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Product Offered
        11.4.3 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 Vicks (Procter & Gamble) Main Business Overview
        11.4.5 Vicks (Procter & Gamble) Latest Developments
    11.5 Natrol
        11.5.1 Natrol Company Information
        11.5.2 Natrol Circadian Rhythm Sleep Disorders Drug Product Offered
        11.5.3 Natrol Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 Natrol Main Business Overview
        11.5.5 Natrol Latest Developments
    11.6 Nature Made (Pharmavite)
        11.6.1 Nature Made (Pharmavite) Company Information
        11.6.2 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Product Offered
        11.6.3 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 Nature Made (Pharmavite) Main Business Overview
        11.6.5 Nature Made (Pharmavite) Latest Developments
    11.7 Jameison
        11.7.1 Jameison Company Information
        11.7.2 Jameison Circadian Rhythm Sleep Disorders Drug Product Offered
        11.7.3 Jameison Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 Jameison Main Business Overview
        11.7.5 Jameison Latest Developments
    11.8 GNC
        11.8.1 GNC Company Information
        11.8.2 GNC Circadian Rhythm Sleep Disorders Drug Product Offered
        11.8.3 GNC Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 GNC Main Business Overview
        11.8.5 GNC Latest Developments
    11.9 By-Health
        11.9.1 By-Health Company Information
        11.9.2 By-Health Circadian Rhythm Sleep Disorders Drug Product Offered
        11.9.3 By-Health Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 By-Health Main Business Overview
        11.9.5 By-Health Latest Developments
    11.10 Now Foods
        11.10.1 Now Foods Company Information
        11.10.2 Now Foods Circadian Rhythm Sleep Disorders Drug Product Offered
        11.10.3 Now Foods Circadian Rhythm Sleep Disorders Drug Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 Now Foods Main Business Overview
        11.10.5 Now Foods Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Circadian Rhythm Sleep Disorders Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Circadian Rhythm Sleep Disorders Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Melatonin
 Table 4. Major Players of Ramelteon
 Table 5. Major Players of Others
 Table 6. Circadian Rhythm Sleep Disorders Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 7. Global Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025) & ($ millions)
 Table 8. Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type (2020-2025)
 Table 9. Circadian Rhythm Sleep Disorders Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 10. Global Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025) & ($ millions)
 Table 11. Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application (2020-2025)
 Table 12. Global Circadian Rhythm Sleep Disorders Drug Revenue by Player (2020-2025) & ($ millions)
 Table 13. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Player (2020-2025)
 Table 14. Circadian Rhythm Sleep Disorders Drug Key Players Head office and Products Offered
 Table 15. Circadian Rhythm Sleep Disorders Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 16. New Products and Potential Entrants
 Table 17. Mergers & Acquisitions, Expansion
 Table 18. Global Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025) & ($ millions)
 Table 19. Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region (2020-2025)
 Table 20. Global Circadian Rhythm Sleep Disorders Drug Revenue by Country/Region (2020-2025) & ($ millions)
 Table 21. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Country/Region (2020-2025)
 Table 22. Americas Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & ($ millions)
 Table 23. Americas Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Country (2020-2025)
 Table 24. Americas Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025) & ($ millions)
 Table 25. Americas Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type (2020-2025)
 Table 26. Americas Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025) & ($ millions)
 Table 27. Americas Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application (2020-2025)
 Table 28. APAC Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025) & ($ millions)
 Table 29. APAC Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region (2020-2025)
 Table 30. APAC Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025) & ($ millions)
 Table 31. APAC Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025) & ($ millions)
 Table 32. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2020-2025) & ($ millions)
 Table 33. Europe Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Country (2020-2025)
 Table 34. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025) & ($ millions)
 Table 35. Europe Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025) & ($ millions)
 Table 36. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Region (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Type (2020-2025) & ($ millions)
 Table 38. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Application (2020-2025) & ($ millions)
 Table 39. Key Market Drivers & Growth Opportunities of Circadian Rhythm Sleep Disorders Drug
 Table 40. Key Market Challenges & Risks of Circadian Rhythm Sleep Disorders Drug
 Table 41. Key Industry Trends of Circadian Rhythm Sleep Disorders Drug
 Table 42. Global Circadian Rhythm Sleep Disorders Drug Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 43. Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share Forecast by Region (2026-2031)
 Table 44. Global Circadian Rhythm Sleep Disorders Drug Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 45. Global Circadian Rhythm Sleep Disorders Drug Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 46. Teva Pharmaceuticals Details, Company Type, Circadian Rhythm Sleep Disorders Drug Area Served and Its Competitors
 Table 47. Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Product Offered
 Table 48. Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 49. Teva Pharmaceuticals Main Business
 Table 50. Teva Pharmaceuticals Latest Developments
 Table 51. Takeda Pharmaceutical Details, Company Type, Circadian Rhythm Sleep Disorders Drug Area Served and Its Competitors
 Table 52. Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Product Offered
 Table 53. Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 54. Takeda Pharmaceutical Main Business
 Table 55. Takeda Pharmaceutical Latest Developments
 Table 56. NBTY Details, Company Type, Circadian Rhythm Sleep Disorders Drug Area Served and Its Competitors
 Table 57. NBTY Circadian Rhythm Sleep Disorders Drug Product Offered
 Table 58. NBTY Circadian Rhythm Sleep Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 59. NBTY Main Business
 Table 60. NBTY Latest Developments
 Table 61. Vicks (Procter & Gamble) Details, Company Type, Circadian Rhythm Sleep Disorders Drug Area Served and Its Competitors
 Table 62. Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Product Offered
 Table 63. Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 64. Vicks (Procter & Gamble) Main Business
 Table 65. Vicks (Procter & Gamble) Latest Developments
 Table 66. Natrol Details, Company Type, Circadian Rhythm Sleep Disorders Drug Area Served and Its Competitors
 Table 67. Natrol Circadian Rhythm Sleep Disorders Drug Product Offered
 Table 68. Natrol Circadian Rhythm Sleep Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 69. Natrol Main Business
 Table 70. Natrol Latest Developments
 Table 71. Nature Made (Pharmavite) Details, Company Type, Circadian Rhythm Sleep Disorders Drug Area Served and Its Competitors
 Table 72. Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Product Offered
 Table 73. Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 74. Nature Made (Pharmavite) Main Business
 Table 75. Nature Made (Pharmavite) Latest Developments
 Table 76. Jameison Details, Company Type, Circadian Rhythm Sleep Disorders Drug Area Served and Its Competitors
 Table 77. Jameison Circadian Rhythm Sleep Disorders Drug Product Offered
 Table 78. Jameison Circadian Rhythm Sleep Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 79. Jameison Main Business
 Table 80. Jameison Latest Developments
 Table 81. GNC Details, Company Type, Circadian Rhythm Sleep Disorders Drug Area Served and Its Competitors
 Table 82. GNC Circadian Rhythm Sleep Disorders Drug Product Offered
 Table 83. GNC Circadian Rhythm Sleep Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 84. GNC Main Business
 Table 85. GNC Latest Developments
 Table 86. By-Health Details, Company Type, Circadian Rhythm Sleep Disorders Drug Area Served and Its Competitors
 Table 87. By-Health Circadian Rhythm Sleep Disorders Drug Product Offered
 Table 88. By-Health Circadian Rhythm Sleep Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 89. By-Health Main Business
 Table 90. By-Health Latest Developments
 Table 91. Now Foods Details, Company Type, Circadian Rhythm Sleep Disorders Drug Area Served and Its Competitors
 Table 92. Now Foods Circadian Rhythm Sleep Disorders Drug Product Offered
 Table 93. Now Foods Circadian Rhythm Sleep Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 94. Now Foods Main Business
 Table 95. Now Foods Latest Developments


List of Figures
 Figure 1. Circadian Rhythm Sleep Disorders Drug Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Circadian Rhythm Sleep Disorders Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Circadian Rhythm Sleep Disorders Drug Sales Market Share by Country/Region (2024)
 Figure 8. Circadian Rhythm Sleep Disorders Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type in 2024
 Figure 10. Circadian Rhythm Sleep Disorders Drug in Delayed Sleep Phase Syndrome (DSPS)
 Figure 11. Global Circadian Rhythm Sleep Disorders Drug Market: Delayed Sleep Phase Syndrome (DSPS) (2020-2025) & ($ millions)
 Figure 12. Circadian Rhythm Sleep Disorders Drug in Advanced Sleep Phase Syndrome (ASPS)
 Figure 13. Global Circadian Rhythm Sleep Disorders Drug Market: Advanced Sleep Phase Syndrome (ASPS) (2020-2025) & ($ millions)
 Figure 14. Circadian Rhythm Sleep Disorders Drug in Irregular Sleep-Wake Disorder (ISWD)
 Figure 15. Global Circadian Rhythm Sleep Disorders Drug Market: Irregular Sleep-Wake Disorder (ISWD) (2020-2025) & ($ millions)
 Figure 16. Circadian Rhythm Sleep Disorders Drug in Others
 Figure 17. Global Circadian Rhythm Sleep Disorders Drug Market: Others (2020-2025) & ($ millions)
 Figure 18. Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application in 2024
 Figure 19. Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Player in 2024
 Figure 20. Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region (2020-2025)
 Figure 21. Americas Circadian Rhythm Sleep Disorders Drug Market Size 2020-2025 ($ millions)
 Figure 22. APAC Circadian Rhythm Sleep Disorders Drug Market Size 2020-2025 ($ millions)
 Figure 23. Europe Circadian Rhythm Sleep Disorders Drug Market Size 2020-2025 ($ millions)
 Figure 24. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size 2020-2025 ($ millions)
 Figure 25. Americas Circadian Rhythm Sleep Disorders Drug Value Market Share by Country in 2024
 Figure 26. United States Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 27. Canada Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 28. Mexico Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 29. Brazil Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 30. APAC Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region in 2024
 Figure 31. APAC Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type (2020-2025)
 Figure 32. APAC Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application (2020-2025)
 Figure 33. China Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 34. Japan Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 35. South Korea Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 36. Southeast Asia Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 37. India Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 38. Australia Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 39. Europe Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Country in 2024
 Figure 40. Europe Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type (2020-2025)
 Figure 41. Europe Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application (2020-2025)
 Figure 42. Germany Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 43. France Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 44. UK Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 45. Italy Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 46. Russia Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 47. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Region (2020-2025)
 Figure 48. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Type (2020-2025)
 Figure 49. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size Market Share by Application (2020-2025)
 Figure 50. Egypt Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 51. South Africa Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 52. Israel Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 53. Turkey Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 54. GCC Countries Circadian Rhythm Sleep Disorders Drug Market Size Growth 2020-2025 ($ millions)
 Figure 55. Americas Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 56. APAC Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 57. Europe Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 58. Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 59. United States Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 60. Canada Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 61. Mexico Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 62. Brazil Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 63. China Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 64. Japan Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 65. Korea Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 66. Southeast Asia Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 67. India Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 68. Australia Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 69. Germany Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 70. France Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 71. UK Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 72. Italy Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 73. Russia Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 74. Egypt Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 75. South Africa Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 76. Israel Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 77. Turkey Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)
 Figure 78. Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share Forecast by Type (2026-2031)
 Figure 79. Global Circadian Rhythm Sleep Disorders Drug Market Size Market Share Forecast by Application (2026-2031)
 Figure 80. GCC Countries Circadian Rhythm Sleep Disorders Drug Market Size 2026-2031 ($ millions)

Companies Mentioned

Teva Pharmaceuticals

Takeda Pharmaceutical

NBTY

Vicks (Procter & Gamble)

Natrol

Nature Made (Pharmavite)

Jameison

GNC

By-Health

Now Foods

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff